Literature DB >> 25547780

Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.

Fumi Miyagawa1, Ayako Hasegawa1, Kyoko Imoto1, Kohei Ogawa1, Nobuhiko Kobayashi1, Kayoko Ito2, Hiroyuki Fujita2, Michiko Aihara2, Hideaki Watanabe3, Hirohiko Sueki3, Mikiko Tohyama4, Hideo Asada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25547780     DOI： 10.1684/ejd.2014.2477

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  4 in total

Review 1.  Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.

Authors:  Luckshman Ganeshanandan; Michaela Lucas
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 2.  Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).

Authors:  Fumi Miyagawa; Hideo Asada
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

3.  Correlation Between Expression of CD134, a Human Herpesvirus 6 Cellular Receptor, on CD4+ T cells and Th2-type Immune Responses in Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.

Authors:  Fumi Miyagawa; Yuki Nakamura-Nishimura; Yushi Kanatani; Hideo Asada
Journal:  Acta Derm Venereol       Date:  2020-03-31       Impact factor: 3.875

4.  Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.

Authors:  Takehiro Hasegawa; Atsushi Nakagawa; Kohjin Suzuki; Kazuto Yamashita; Saya Yamashita; Niina Iwanaga; Eiya Tamada; Kenta Noda; Keisuke Tomii
Journal:  Cytokine       Date:  2021-06-07       Impact factor: 3.861
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.